Foreign Drugs Welcome As China Reforms Progress: CFDA Commissioner

China’s drug regulators have had plenty of views to offer at recent major government congress sessions in Beijing, which provide a forum for the industry to meet officials and opportunities to outline reform progress and planned policies.